Effect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium

dc.contributor.authorCoskun, Ebru
dc.contributor.authorCakiroglu, Yigit
dc.contributor.authorAygun, Banu Kumbak
dc.contributor.authorMuezzinoglu, Bahar
dc.contributor.authorCaliskan, Eray
dc.date.accessioned2026-08-12T17:31:29Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: To evaluate the effect of copper intrauterine device (IUD) on the expression of cyclooxygenase (COX) and inducible nitric oxide synthase (iNOS) in the luteal phase endometrium. Study Design: A prospective clinical study was conducted on 30 women who were willing to use a copper IUD contraception. Endometrial biopsies and blood samples were taken before and 3 months after the insertion of the IUD on Day 3 and Days 20-24 of the cycle. Main outcome measures were to evaluate the effect of copper IUD on uterine artery blood flow using pulsed color Doppler ultrasonography and the relationship of bleeding abnormalities and menstrual pain level with the uterine blood flow, COX-2 and iNOS expression. Results: Only the left uterine artery pulsatility and resistance indices decreased statistically significantly (p=.005 and p=.039, respectively). Other Doppler parameters showed no change. Cyclooxygenase-2 expression of both endometrial luminal epithelium (p=.03) and gland epithelium (p=.03) increased significantly. Inducible NOS expression of the endometrial surface epithelium decreased significantly after IUD insertion (p=.01). Conclusions: Although COX-2 expression increased 3 months after copper IUD insertion, iNOS expression of the luminal epithelium decreased. Local hypoxia caused by copper and vasoconstrictor prostanoids may play a role in IUD-related menstrual abnormalities. (C) 2011 Elsevier Inc. All rights reserved.
dc.description.sponsorshipKocaeli University
dc.description.sponsorshipThis study was funded by the Kocaeli University Research Support Programme.
dc.identifier.doi10.1016/j.contraception.2011.03.027
dc.identifier.endpage641
dc.identifier.issn0010-7824
dc.identifier.issn1879-0518
dc.identifier.issue6
dc.identifier.pmid22078195
dc.identifier.scopus2-s2.0-81155137793
dc.identifier.scopusqualityQ1
dc.identifier.startpage637
dc.identifier.urihttps://doi.org/10.1016/j.contraception.2011.03.027
dc.identifier.urihttps://hdl.handle.net/11508/56260
dc.identifier.volume84
dc.identifier.wosWOS:000297714100016
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofContraception
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectCOX-2
dc.subjectiNOS
dc.subjectTCu380A
dc.subjectMenstrual abnormalities
dc.subjectDysmenorrhea
dc.titleEffect of copper intrauterine device on the cyclooxygenase and inducible nitric oxide synthase expression in the luteal phase endometrium
dc.typeArticle

Dosyalar